Corlanor®(ivabradine) Tablets
Annual Sales
Company AMGEN
Date of First Filing October 15, 2019
Paragraph IV Applicant: Torrent
Case Name: AMGEN INC et al v. TORRENT PHARMA INC et al
Court/Case #: Delaware District Court (dedc) 1:2020cv00065
Date Filed: 1/16/20
Judge:
Product Strength:
Litigated Patents (expiration): 7,361,64…[Read more]
The Paragraph Four Report®
Paragraph IV Activity for December 2019
New Certifications as reported by FDA on December 3, 2019
1. Carlanor®(ivabradine) Tablets 5mg and 7.5mg on October 15, 2019
2. Veltassa®(patiromer) for Oral Suspension 8.4mg, 16,8mg, and 25.2mg on October 21, 2019
Comments: The two products on the December list have ac…[Read more]
Vraylar®(cariprazine) Capsules
Annual Sales $487M
Company ALLERGAN
Date of First Filing September 17, 2019
Paragraph IV Applicant: Sun, Aurobindo, Zydus
Case Name: ALLERGAN USA INC et al v. SUN PHARMACEUTICASL INDUSTRIES LIMITED et al
Court/Case #: Delaware District Court (dedc) 1:2019cv02317
Date Filed: 12/20/19
Judge: Andrews
Prod…[Read more]
